Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma

Said M. Afify, Ghmkin Hassan, Amira Osman, Anna Sanchez Calle, Hend M. Nawara, Maram Hussein Zahra, Samah El-Ghlban, Hager Mansour, Md Jahangir Alam, Hagar A. Abu Quora, Juan Du, Akimasa Seno, Yoshiaki Iwasaki, Masaharu Seno

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Metastasis develops when cancer cells spread from the primary site of a malignant tumor to the surrounding and distant tissues, and it is the most critical problem in cancer treatment. Our group developed cancer stem cells (CSCs) from induced pluripotent stem cells (iPSCs) in the presence of a conditioned medium (CM) of cancer-derived cells. The CSCs were characterized by the formation of malignant tumors in vivo, followed by metastasis. In this study, CSCs converted from mouse iPSCs in the presence of CM from hepatocellular carcinoma (HCC) cell line Huh7 cells. These converted cells (miPS-Huh7cm cells) were established as the metastatic cells. The generated CSCs were injected into the liver or spleen of nude mice. Almost one month after transplantation, the tumors were excised, and the primary cultured cells derived from the malignant tumors and metastatic nodules were evaluated by stemness and metastatic markers to compare their differences. The miPS-Huh7cm cells exhibited metastatic potential, and efficiently formed malignant tumors with lung and/or liver lesions in vivo, whereas the injected miPS formed teratoma. The primary cultured cells derived from the malignant tumors and metastatic nodules sustained the expression of stemness markers, such as Nanog, Klf4 and c-Myc, and acquired cancer stem markers, such as CD90, CD44 and ALDH1. Simultaneously, the expression of metastatic markers, such as Slug, Twist1 and vimentin, in primary cells derived from the malignant tumors, was higher than in metastatic nodules. The CSCs derived from iPSCs, forming malignant tumors and displaying high metastasis, will provide a good animal model to study the mechanisms of metastasis.

Original languageEnglish
Article number73
JournalBioengineering
Volume6
Issue number3
DOIs
Publication statusPublished - Sep 2019

Fingerprint

Stem cells
Tumors
Cells
Conditioned Culture Medium
Liver
Oncology
Vimentin
Animals
Tissue

Keywords

  • Cancer stem cells
  • Metastasis
  • Stem cells

ASJC Scopus subject areas

  • Bioengineering

Cite this

Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma. / Afify, Said M.; Hassan, Ghmkin; Osman, Amira; Calle, Anna Sanchez; Nawara, Hend M.; Zahra, Maram Hussein; El-Ghlban, Samah; Mansour, Hager; Alam, Md Jahangir; Abu Quora, Hagar A.; Du, Juan; Seno, Akimasa; Iwasaki, Yoshiaki; Seno, Masaharu.

In: Bioengineering, Vol. 6, No. 3, 73, 09.2019.

Research output: Contribution to journalArticle

Afify, SM, Hassan, G, Osman, A, Calle, AS, Nawara, HM, Zahra, MH, El-Ghlban, S, Mansour, H, Alam, MJ, Abu Quora, HA, Du, J, Seno, A, Iwasaki, Y & Seno, M 2019, 'Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma', Bioengineering, vol. 6, no. 3, 73. https://doi.org/10.3390/bioengineering6030073
Afify, Said M. ; Hassan, Ghmkin ; Osman, Amira ; Calle, Anna Sanchez ; Nawara, Hend M. ; Zahra, Maram Hussein ; El-Ghlban, Samah ; Mansour, Hager ; Alam, Md Jahangir ; Abu Quora, Hagar A. ; Du, Juan ; Seno, Akimasa ; Iwasaki, Yoshiaki ; Seno, Masaharu. / Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma. In: Bioengineering. 2019 ; Vol. 6, No. 3.
@article{e89dd0bbd3cb4fd58aea8ef859100dcc,
title = "Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma",
abstract = "Metastasis develops when cancer cells spread from the primary site of a malignant tumor to the surrounding and distant tissues, and it is the most critical problem in cancer treatment. Our group developed cancer stem cells (CSCs) from induced pluripotent stem cells (iPSCs) in the presence of a conditioned medium (CM) of cancer-derived cells. The CSCs were characterized by the formation of malignant tumors in vivo, followed by metastasis. In this study, CSCs converted from mouse iPSCs in the presence of CM from hepatocellular carcinoma (HCC) cell line Huh7 cells. These converted cells (miPS-Huh7cm cells) were established as the metastatic cells. The generated CSCs were injected into the liver or spleen of nude mice. Almost one month after transplantation, the tumors were excised, and the primary cultured cells derived from the malignant tumors and metastatic nodules were evaluated by stemness and metastatic markers to compare their differences. The miPS-Huh7cm cells exhibited metastatic potential, and efficiently formed malignant tumors with lung and/or liver lesions in vivo, whereas the injected miPS formed teratoma. The primary cultured cells derived from the malignant tumors and metastatic nodules sustained the expression of stemness markers, such as Nanog, Klf4 and c-Myc, and acquired cancer stem markers, such as CD90, CD44 and ALDH1. Simultaneously, the expression of metastatic markers, such as Slug, Twist1 and vimentin, in primary cells derived from the malignant tumors, was higher than in metastatic nodules. The CSCs derived from iPSCs, forming malignant tumors and displaying high metastasis, will provide a good animal model to study the mechanisms of metastasis.",
keywords = "Cancer stem cells, Metastasis, Stem cells",
author = "Afify, {Said M.} and Ghmkin Hassan and Amira Osman and Calle, {Anna Sanchez} and Nawara, {Hend M.} and Zahra, {Maram Hussein} and Samah El-Ghlban and Hager Mansour and Alam, {Md Jahangir} and {Abu Quora}, {Hagar A.} and Juan Du and Akimasa Seno and Yoshiaki Iwasaki and Masaharu Seno",
year = "2019",
month = "9",
doi = "10.3390/bioengineering6030073",
language = "English",
volume = "6",
journal = "Bioengineering",
issn = "2306-5354",
publisher = "MDPI AG",
number = "3",

}

TY - JOUR

T1 - Metastasis of cancer stem cells developed in the microenvironment of hepatocellular carcinoma

AU - Afify, Said M.

AU - Hassan, Ghmkin

AU - Osman, Amira

AU - Calle, Anna Sanchez

AU - Nawara, Hend M.

AU - Zahra, Maram Hussein

AU - El-Ghlban, Samah

AU - Mansour, Hager

AU - Alam, Md Jahangir

AU - Abu Quora, Hagar A.

AU - Du, Juan

AU - Seno, Akimasa

AU - Iwasaki, Yoshiaki

AU - Seno, Masaharu

PY - 2019/9

Y1 - 2019/9

N2 - Metastasis develops when cancer cells spread from the primary site of a malignant tumor to the surrounding and distant tissues, and it is the most critical problem in cancer treatment. Our group developed cancer stem cells (CSCs) from induced pluripotent stem cells (iPSCs) in the presence of a conditioned medium (CM) of cancer-derived cells. The CSCs were characterized by the formation of malignant tumors in vivo, followed by metastasis. In this study, CSCs converted from mouse iPSCs in the presence of CM from hepatocellular carcinoma (HCC) cell line Huh7 cells. These converted cells (miPS-Huh7cm cells) were established as the metastatic cells. The generated CSCs were injected into the liver or spleen of nude mice. Almost one month after transplantation, the tumors were excised, and the primary cultured cells derived from the malignant tumors and metastatic nodules were evaluated by stemness and metastatic markers to compare their differences. The miPS-Huh7cm cells exhibited metastatic potential, and efficiently formed malignant tumors with lung and/or liver lesions in vivo, whereas the injected miPS formed teratoma. The primary cultured cells derived from the malignant tumors and metastatic nodules sustained the expression of stemness markers, such as Nanog, Klf4 and c-Myc, and acquired cancer stem markers, such as CD90, CD44 and ALDH1. Simultaneously, the expression of metastatic markers, such as Slug, Twist1 and vimentin, in primary cells derived from the malignant tumors, was higher than in metastatic nodules. The CSCs derived from iPSCs, forming malignant tumors and displaying high metastasis, will provide a good animal model to study the mechanisms of metastasis.

AB - Metastasis develops when cancer cells spread from the primary site of a malignant tumor to the surrounding and distant tissues, and it is the most critical problem in cancer treatment. Our group developed cancer stem cells (CSCs) from induced pluripotent stem cells (iPSCs) in the presence of a conditioned medium (CM) of cancer-derived cells. The CSCs were characterized by the formation of malignant tumors in vivo, followed by metastasis. In this study, CSCs converted from mouse iPSCs in the presence of CM from hepatocellular carcinoma (HCC) cell line Huh7 cells. These converted cells (miPS-Huh7cm cells) were established as the metastatic cells. The generated CSCs were injected into the liver or spleen of nude mice. Almost one month after transplantation, the tumors were excised, and the primary cultured cells derived from the malignant tumors and metastatic nodules were evaluated by stemness and metastatic markers to compare their differences. The miPS-Huh7cm cells exhibited metastatic potential, and efficiently formed malignant tumors with lung and/or liver lesions in vivo, whereas the injected miPS formed teratoma. The primary cultured cells derived from the malignant tumors and metastatic nodules sustained the expression of stemness markers, such as Nanog, Klf4 and c-Myc, and acquired cancer stem markers, such as CD90, CD44 and ALDH1. Simultaneously, the expression of metastatic markers, such as Slug, Twist1 and vimentin, in primary cells derived from the malignant tumors, was higher than in metastatic nodules. The CSCs derived from iPSCs, forming malignant tumors and displaying high metastasis, will provide a good animal model to study the mechanisms of metastasis.

KW - Cancer stem cells

KW - Metastasis

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=85073381128&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073381128&partnerID=8YFLogxK

U2 - 10.3390/bioengineering6030073

DO - 10.3390/bioengineering6030073

M3 - Article

AN - SCOPUS:85073381128

VL - 6

JO - Bioengineering

JF - Bioengineering

SN - 2306-5354

IS - 3

M1 - 73

ER -